EGF Theramed Health Corp.
TMED
CNSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 22.50K | 78.10K | 39.20K | 48.00K | 23.40K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 22.50K | 78.10K | 39.20K | 48.00K | 23.40K |
| Operating Income | -22.50K | -78.10K | -39.20K | -48.00K | -23.40K |
| Income Before Tax | -44.50K | -1.49M | -52.20K | -154.00K | -29.30K |
| Income Tax Expenses | -- | 598.20K | -- | 3.10K | -- |
| Earnings from Continuing Operations | -44.50K | -2.09M | -52.20K | -157.10K | -29.30K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 8.70K | -3.30K | 3.50K | 15.00K | 1.30K |
| Net Income | -35.80K | -2.10M | -48.70K | -142.10K | -27.90K |
| EBIT | -22.50K | -78.10K | -39.20K | -48.00K | -23.40K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.00 | -0.18 | 0.00 | -0.01 | 0.00 |
| Normalized Basic EPS | 0.00 | -0.08 | 0.00 | -0.01 | 0.00 |
| EPS Diluted | 0.00 | -0.18 | 0.00 | -0.01 | 0.00 |
| Normalized Diluted EPS | 0.00 | -0.08 | 0.00 | -0.01 | 0.00 |
| Average Basic Shares Outstanding | 11.62M | 11.62M | 11.62M | 11.62M | 11.54M |
| Average Diluted Shares Outstanding | 11.62M | 11.62M | 11.62M | 11.62M | 11.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |